Biblio

Zinc Fingers

C. M. Karch, Ezerskiy, L. A., Bertelsen, S., and Goate, A. M., “Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.”, PLoS One, vol. 11, no. 2, p. e0148717, 2016.

Young Adult

C. U. Greven, Bralten, J., Mennes, M., O'Dwyer, L., van Hulzen, K. J. E., Rommelse, N., Schweren, L. J. S., Hoekstra, P. J., Hartman, C. A., Heslenfeld, D., Oosterlaan, J., Faraone, S. V., Franke, B., Zwiers, M. P., Arias-Vasquez, A., and Buitelaar, J. K., “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.

G. V. Roshchupkin, Gutman, B. A., Vernooij, M. W., Jahanshad, N., Martin, N. G., Hofman, A., McMahon, K. L., van der Lee, S. J., van Duijn, C. M., de Zubicaray, G. I., Uitterlinden, A. G., Wright, M. J., Niessen, W. J., Thompson, P. M., M Ikram, A., and Adams, H. H. H., “Heritability of the shape of subcortical brain structures in the general population.”, Nat Commun, vol. 7, p. 13738, 2016.

Wound Healing

Y. Deming, Xia, J., Cai, Y., Lord, J., Holmans, P., Bertelsen, S., Holtzman, D., Morris, J. C., Bales, K., Pickering, E. H., Kauwe, J., Goate, A., and Cruchaga, C., “A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.”, Neurobiol Aging, vol. 37, pp. 208.e1-208.e9, 2016.

Wnt Proteins

V. Busby, Goossens, S., Nowotny, P., Hamilton, G., Smemo, S., Harold, D., Turic, D., Jehu, L., Myers, A., Womick, M., Woo, D., Compton, D., Doil, L. M., Tacey, K. M., Lau, K. F., Al-Saraj, S., Killick, R., Pickering-Brown, S., Moore, P., Hollingworth, P., Archer, N., Foy, C., Walter, S., Lendon, C., Iwatsubo, T., Morris, J. C., Norton, J., Mann, D., Janssens, B., Hardy, J., O'Donovan, M., Jones, L., Williams, J., Holmans, P., Owen, M. J., Grupe, A., Powell, J., van Hengel, J., Goate, A., Van Roy, F., and Lovestone, S., “Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.”, Neuromolecular Med, vol. 5, no. 2, pp. 133-46, 2004.

White Matter

C. U. Greven, Bralten, J., Mennes, M., O'Dwyer, L., van Hulzen, K. J. E., Rommelse, N., Schweren, L. J. S., Hoekstra, P. J., Hartman, C. A., Heslenfeld, D., Oosterlaan, J., Faraone, S. V., Franke, B., Zwiers, M. P., Arias-Vasquez, A., and Buitelaar, J. K., “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.

Washington

E. S. O'Meara, Kukull, W. A., Sheppard, L., Bowen, J. D., McCormick, W. C., Teri, L., Pfanschmidt, M., Thompson, J. D., Schellenberg, G. D., and Larson, E. B., “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.

Vertebrates

Y. - C. Hwang, Zheng, Q., Gregory, B. D., and San Wang, L. -, “High-throughput identification of long-range regulatory elements and their target promoters in the human genome.”, Nucleic Acids Res, vol. 41, no. 9, pp. 4835-46, 2013.

Valine

F. W. Lohoff, Sander, T., Ferraro, T. N., Dahl, J. P., Gallinat, J., and Berrettini, W. H., “Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.”, Am J Med Genet B Neuropsychiatr Genet, vol. 139B, no. 1, pp. 51-3, 2005.

Urokinase-Type Plasminogen Activator

A. J. Myers, Marshall, H., Holmans, P., Compton, D., Crook, R. J. P., Mander, A. P., Nowotny, P., Smemo, S., Dunstan, M., Jehu, L., Wang, J. C., Hamshere, M., Morris, J. C., Norton, J., Chakraventy, S., Tunstall, N., Lovestone, S., Petersen, R., O'Donovan, M., Jones, L., Williams, J., Owen, M. J., Hardy, J., and Goate, A., “Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.”, Am J Med Genet B Neuropsychiatr Genet, vol. 124B, no. 1, pp. 29-37, 2004.

N. Ertekin-Taner, Ronald, J., Feuk, L., Prince, J., Tucker, M., Younkin, L., Hella, M., Jain, S., Hackett, A., Scanlin, L., Kelly, J., Kihiko-Ehman, M., Neltner, M., Hersh, L., Kindy, M., Markesbery, W., Hutton, M., de Andrade, M., Petersen, R. C., Graff-Radford, N., Estus, S., Brookes, A. J., and Younkin, S. G., “Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.”, Hum Mol Genet, vol. 14, no. 3, pp. 447-60, 2005.

Up-Regulation

D. Mastroeni, Sekar, S., Nolz, J., Delvaux, E., Lunnon, K., Mill, J., Liang, W. S., and Coleman, P. D., “ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.”, PLoS One, vol. 12, no. 7, p. e0177814, 2017.

United States Dept. of Health and Human Services

G. McKhann, Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M., “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.”, Neurology, vol. 34, no. 7, pp. 939-44, 1984.

United States

R. S. Desikan, Fan, C. Chieh, Wang, Y., Schork, A. J., Cabral, H. J., L Cupples, A., Thompson, W. K., Besser, L., Kukull, W. A., Holland, D., Chen, C. - H., Brewer, J. B., Karow, D. S., Kauppi, K., Witoelar, A., Karch, C. M., Bonham, L. W., Yokoyama, J. S., Rosen, H. J., Miller, B. L., Dillon, W. P., Wilson, D. M., Hess, C. P., Pericak-Vance, M., Haines, J. L., Farrer, L. A., Mayeux, R., Hardy, J., Goate, A. M., Hyman, B. T., Schellenberg, G. D., McEvoy, L. K., Andreassen, O. A., and Dale, A. M., “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.

K. G. Manton and Gu, X., “Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.”, Proc Natl Acad Sci U S A, vol. 98, no. 11, pp. 6354-9, 2001.

Y. - J. Li, Scott, W. K., Zhang, L., Lin, P. - I., Oliveira, S. A., Skelly, T., Doraiswamy, M. P., Welsh-Bohmer, K. A., Martin, E. R., Haines, J. L., Pericak-Vance, M. A., and Vance, J. M., “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.

J. H. Lee, Cheng, R., Graff-Radford, N., Foroud, T., and Mayeux, R., “Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.”, Arch Neurol, vol. 65, no. 11, pp. 1518-26, 2008.

L. - San Wang, Naj, A. C., Graham, R. R., Crane, P. K., Kunkle, B. W., Cruchaga, C., Murcia, J. D. Gonzalez, Cannon-Albright, L., Baldwin, C. T., Zetterberg, H., Blennow, K., Kukull, W. A., Faber, K. M., Schupf, N., Norton, M. C., Tschanz, J. A. T., Munger, R. G., Corcoran, C. D., Rogaeva, E., Lin, C. - F., Dombroski, B. A., Cantwell, L. B., Partch, A., Valladares, O., Hakonarson, H., St George-Hyslop, P., Green, R. C., Goate, A. M., Foroud, T. M., Carney, R. M., Larson, E. B., Behrens, T. W., Kauwe, J. S. K., Haines, J. L., Farrer, L. A., Pericak-Vance, M. A., Mayeux, R., Schellenberg, G. D., Albert, M. S., Albin, R. L., Apostolova, L. G., Arnold, S. E., Barber, R., Barmada, M., Barnes, L. L., Beach, T. G., Becker, J. T., Beecham, G. W., Beekly, D., Bennett, D. A., Bigio, E. H., Bird, T. D., Blacker, D., Boeve, B. F., Bowen, J. D., Boxer, A., Burke, J. R., Buxbaum, J. D., Cairns, N. J., Cao, C., Carlson, C. S., Carroll, S. L., Chui, H. C., Clark, D. G., Cribbs, D. H., Crocco, E. A., DeCarli, C., DeKosky, S. T., F Demirci, Y., Dick, M., Dickson, D. W., Duara, R., Ertekin-Taner, N., Fallon, K. B., Farlow, M. R., Ferris, S., Frosch, M. P., Galasko, D. R., Ganguli, M., Gearing, M., Geschwind, D. H., Ghetti, B., Gilbert, J. R., Glass, J. D., Graff-Radford, N. R., Growdon, J. H., Hamilton, R. L., Hamilton-Nelson, K. L., Harrell, L. E., Head, E., Honig, L. S., Hulette, C. M., Hyman, B. T., Jarvik, G. P., Jicha, G. A., Jin, L. - W., Jun, G., Jun, G., M Kamboh, I., Karydas, A., Kaye, J. A., Kim, R., Koo, E. H., Kowall, N. W., Kramer, J. H., LaFerla, F. M., Lah, J. J., Leverenz, J. B., Levey, A. I., Li, G., Lieberman, A. P., Lopez, O. L., Lunetta, K. L., Lyketsos, C. G., Mack, W. J., Marson, D. C., Martin, E. R., Martiniuk, F., Mash, D. C., Masliah, E., McCormick, W. C., McCurry, S. M., McDavid, A. N., McKee, A. C., W Mesulam, M., Miller, B. L., Miller, C. A., Miller, J. W., Montine, T. J., Morris, J. C., Murrell, J. R., Olichney, J. M., Parisi, J. E., Perry, W., Peskind, E., Petersen, R. C., Pierce, A., Poon, W. W., Potter, H., Quinn, J. F., Raj, A., Raskind, M., Reiman, E. M., Reisberg, B., Reitz, C., Ringman, J. M., Roberson, E. D., Rosen, H. J., Rosenberg, R. N., Sano, M., Saykin, A. J., Schneider, J. A., Schneider, L. S., Seeley, W. W., Smith, A. G., Sonnen, J. A., Spina, S., Stern, R. A., Tanzi, R. E., Thornton-Wells, T. A., Trojanowski, J. Q., Troncoso, J. C., Tsuang, D. W., Van Deerlin, V. M., Van Eldik, L. J., Vardarajan, B. N., Vinters, H. V., Vonsattel, J. Paul, Weintraub, S., Welsh-Bohmer, K. A., Williamson, J., Wishnek, S., Woltjer, R. L., Wright, C. B., Younkin, S. G., Yu, C. - E., and Yu, L., “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.

G. C. Román, Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J. M., Brun, A., and Hofman, A., “Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.”, Neurology, vol. 43, no. 2, pp. 250-60, 1993.

A. Sonnega, Faul, J. D., Ofstedal, M. Beth, Langa, K. M., Phillips, J. W. R., and Weir, D. R., “Cohort Profile: the Health and Retirement Study (HRS).”, Int J Epidemiol, vol. 43, no. 2, pp. 576-85, 2014.

G. McKhann, Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M., “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.”, Neurology, vol. 34, no. 7, pp. 939-44, 1984.

M. Victoria Fernández, Black, K., Carrell, D., Saef, B., Budde, J., Deming, Y., Howells, B., Del-Aguila, J. L., Ma, S., Bi, C., Norton, J., Chasse, R., Morris, J., Goate, A., and Cruchaga, C., “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.

P. M. Erlich, Lunetta, K. L., L Cupples, A., Huyck, M., Green, R. C., Baldwin, C. T., and Farrer, L. A., “Polymorphisms in the PON gene cluster are associated with Alzheimer disease.”, Hum Mol Genet, vol. 15, no. 1, pp. 77-85, 2006.

Unconsciousness

E. S. O'Meara, Kukull, W. A., Sheppard, L., Bowen, J. D., McCormick, W. C., Teri, L., Pfanschmidt, M., Thompson, J. D., Schellenberg, G. D., and Larson, E. B., “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.

Twins, Monozygotic

G. V. Roshchupkin, Gutman, B. A., Vernooij, M. W., Jahanshad, N., Martin, N. G., Hofman, A., McMahon, K. L., van der Lee, S. J., van Duijn, C. M., de Zubicaray, G. I., Uitterlinden, A. G., Wright, M. J., Niessen, W. J., Thompson, P. M., M Ikram, A., and Adams, H. H. H., “Heritability of the shape of subcortical brain structures in the general population.”, Nat Commun, vol. 7, p. 13738, 2016.